Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)
This study has been withdrawn prior to enrollment.
( Sponsor decision to withdraw study to pursue others. )
Study NCT01339949
Information provided by Oraya Therapeutics, Inc.
First Received on April 20, 2011.
Last Updated on December 28, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
